Palo Alto Investors »

Xeris Pharmaceuticals shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $606k 104k 5.80

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
State Street Corporation
Geode Capital Management
Qube Research & Technologies
Rosalind Advisors
Nuveen
Vanguard Portfolio Management
Morgan Stanley
Millennium Management
Wellington Management Company
Two Sigma Investments
Armistice Capital
Legal & General Group

View all funds holding Xeris Pharmaceuticals